Surprise all-clear for Boots/Alliance merger

By Emma Thelwell Mar 03, 2006

1

Share with
friends:

Comments (0) Print this article

If the truth be known, the Office of Fair Trading’s (OFT) decision to give the merger of Boots and Alliance UniChem the all-clear surprised everyone, including the Boots board, says Jeremy Warner in The Independent.

And so it should: the OFT have just waved through a £7.3bn deal that will create the biggest chemists’ chain in Britain – it will have sales of £13bn and account for 19% of the pharmacy market.

What a “sideswipe at the Government’s anti-competitive practices”, says Patience Wheatcroft in The Times. The two firms were expecting a temporary block on their tie-up, and many predicted a full-blown OFT inquiry. The merger, not expected until well into 2007, could now be completed by June.

That leaves little time for a private-equity player to materialise, but Boots’s strong cash flow and potential to build its business should attract a bidder, says Wheatcroft. The share price for both firms rose slightly on the news, and investors are likely to vote in favour of the merger. Warner is not so sure this “hurriedly assembled” deal is a wise move for Boots, but in the absence of any “attractive alternative, it will just have to do”.

Comments (0)

Share with
friends:

Leave a comment

This will be the name displayed with your comment.

This helps us verify comments are genuine. It will not be displayed anywhere on the site and is stored confidentially.

Please keep your comment within 1,000 characters and relevant to the main topic. We encourage healthy debate, but we don't allow insults or bad language. Anything off topic or unpleasant, we'll remove. Enjoy the conversation! Thank you.

captcha To prevent spam-related comments please enter the characters shown in the 'Captcha' box to the left.

By leaving a comment you accept our terms and conditions.


FREE - MoneyWeek's daily investment emailJohn Stepek

Our free daily email, Money Morning, is an informative and enjoyable analysis of what's going on in the markets. Written by our Editor, John Stepek, and guest contributors.
Sign up FREE to Money Morning here.

>